DOPATREEPreview

Open in TheBrain

DOPATREE
ORGANIZATIONS
COMPANIES-ALL (COMPANY, CLIENTS, SPONSORS, SMALL, MID-SIZE, LARGE PHARMA, BIG PHARMA, BIOPHARMA, EMERGING COMPANIES, STARTUPS, START-UPS, SPIN-OFFS, SUBSIDIARIES, SUBSIDIARY, BIOTECHNOLOGY, EMERGING)
COMPANIES / LISTINGS-N
NOVARTIS
NOVARTIS / PRODUCTS / APPROVED
PLUVICTO™ (LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN)
PLUVICTO / WARNINGS AND PRECAUTIONS

EMBRYOFETAL TOXICITY (EMBRYONIC DEVELOPMENT, STUDIES, DEVELOPMENTAL TOXICITY, EMBRYO-FETAL, REPRODUCTIVE TOXICITY, TERATOGENICITY, RISK OF DRUG EXPOSURE DURING PREGNANCY)

Parents

CAMZYOS / WARNINGS AND PRECAUTIONS
CLINICAL PHARMACOLOGY STUDIES / TYPES
LUTATHERA / WARNINGS AND PRECAUTIONS
PLUVICTO / WARNINGS AND PRECAUTIONS
PREGNANCY / RELATED
PREGNANCY STUDY / RELATED
REPRODUCTIVE TOXICITY / RELATED
TREATMENT-RELATED CONDITIONS / LISTINGS

Children

EMBRYOFETAL TOXICITY / LAWS AND REGULATIONS / US
EMBRYOFETAL TOXICITY / MITIGATIONS
EMBRYOFETAL TOXICITY / MITIGATIONS
EMBRYOFETAL TOXICITY / RELATED

Made with TheBrain